Dusseldorf - Delayed Quote EUR

Corvus Pharmaceuticals Inc (C17.DU)

Compare
5.0000 +0.5700 (+12.87%)
At close: December 27 at 7:31:19 PM GMT+1
Loading Chart for C17.DU
DELL
  • Previous Close 4.4300
  • Open 4.9950
  • Bid 4.9500 x --
  • Ask 5.0600 x --
  • Day's Range 4.9650 - 5.0400
  • 52 Week Range 1.2120 - 8.9600
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Mar 17, 2025 - Mar 21, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: C17.DU

View More

Performance Overview: C17.DU

Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

C17.DU
247.71%
S&P 500
25.18%

1-Year Return

C17.DU
247.71%
S&P 500
25.05%

3-Year Return

C17.DU
247.71%
S&P 500
26.35%

5-Year Return

C17.DU
247.71%
S&P 500
84.29%

Compare To: C17.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: C17.DU

View More

Valuation Measures

Annual
As of 12/23/2024
  • Market Cap

    280.32M

  • Enterprise Value

    240.72M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    23.93

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: C17.DU

View More

Company Insights: C17.DU

Research Reports: C17.DU

View More